Mesenchymal stem cells in rheumatoid synovium: enumeration and functional assessment in relation to synovial inflammation level
- 1 February 2010
- journal article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 69 (2) , 450-457
Abstract
Objective: Achieving joint regeneration in rheumatoid arthritis (RA) represents a future challenge. Autologous synovial mesenchymal stem cells (MSCs) could be therapeutically exploited. However, the inflammatory milieu in the RA synovium could adversely affect endogenous MSC function. To test this hypothesis, the frequency and multipotency of RA synovial MSCs was evaluated in relation to existing synovial inflammation. Methods: Synovial inflammation was measured using the arthroscopic visual analogue score (VAS) and further validated using immunohistochemistry and flow cytometry. Highly proliferative clonogenic in vivo MSCs were enumerated following fluorescence-activated cell sorting and expansion for 20 population doublings. MSC multipotency was quantified following standard in vitro culture expansion and trilineage differentiation assays. Real-time PCR, flow cytometry and ELISA were used to evaluate pro- and anti-chondrogenic molecules in standard polyclonal synovial MSCs. Results: The arthroscopic VAS significantly correlated with synovial macrophage infiltration. In RA, synovial MSC chondrogenesis was inhibited in direct relation to VAS (r = −0.777, p−CD31−) and were reduced in frequency in relation to VAS (r = −0.695, pConclusions: There is a negative relationship between synovial MSC chondrogenic and clonogenic capacities and the magnitude of synovitis in RA. Effective suppression of joint inflammation is therefore necessary for the development of autologous MSC treatments aimed at cartilage regeneration in RA.Keywords
This publication has 52 references indexed in Scilit:
- The value of synovial cytokine expression in predicting the clinical response to TNF antagonist therapy (infliximab)Rheumatology, 2008
- Abnormal T cell differentiation persists in patients with rheumatoid arthritis in clinical remission and predicts relapseAnnals of the Rheumatic Diseases, 2008
- Synovial fluid mesenchymal stem cells in health and early osteoarthritis: Detection and functional evaluation at the single‐cell levelArthritis & Rheumatism, 2008
- Mesenchymal Stem Cells: Revisiting History, Concepts, and AssaysCell Stem Cell, 2008
- A biomarker‐based mathematical model to predict bone‐forming potency of human synovial and periosteal mesenchymal stem cellsArthritis & Rheumatism, 2007
- Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their nicheNature Medicine, 2007
- An essential role of NF-κB in the “tumor-like” phenotype of arthritic synoviocytesProceedings of the National Academy of Sciences, 2006
- Stemming cartilage degeneration: Adult mesenchymal stem cells as a cell source for articular cartilage tissue engineeringArthritis & Rheumatism, 2006
- Outcome of intensive immunosuppression and autologous stem cell transplantation in patients with severe rheumatoid arthritis is associated with the composition of synovial T cell infiltrationAnnals of the Rheumatic Diseases, 2005
- Global gene expression profiles in fibroblasts from synovial, skin and lymphoid tissue reveals distinct cytokine and chemokine expression patternsThrombosis and Haemostasis, 2003